Ellsworth Growth and Income Fund Ltd
Change company Symbol lookup
Select an option...
ECF Ellsworth Growth and Income Fund Ltd
SILK Silk Road Medical Inc
HLVX Hillevax Inc
AIZ Assurant Inc
NOTV Inotiv Inc
MYD BlackRock MuniYield
WPC WP Carey Inc
ATCO-I Atlas Corp
ATLX Atlas Lithium Corp
SRRK Scholar Rock Holding Corp
Go

Company profile

Ellsworth Growth and Income Fund Ltd. is a closed-end, diversified management investment company. The Fund’s primary investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The Fund invests primarily in convertible and equity securities. The Fund's portfolio includes sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, diversified industrial, food and beverage, communications equipment, consumer products, transportation, consumer services, cable and satellite, computer hardware, automotive, wireless communications, agriculture and entertainment. Gabelli Funds, LLC is the investment advisor of the Fund.

Closing Price
$8.95
Day's Change
0.18 (2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.97
Day's Low
8.78
Volume
(Light)
Volume:
13,169

10-day average volume:
36,409
13,169

Chemours and Honeywell Announce Program to Enable Reclamation and Recycling of Refrigerants in Support of Circular Economy

7:30 am ET November 16, 2022 (BusinessWire) Print

The Chemours Company ("Chemours") (NYSE: CC), and Honeywell (NASDAQ: HON), today announced the launch of a new pilot program to enable qualified companies to recycle and reclaim R-448A, also known as Honeywell Solstice(R) N40, and R-449A, also known as Opteon(TM) XP40, patented HFO refrigerant blends in the European Union and the United Kingdom.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116005075/en/

In recent years, global regulatory drivers and the increasing need for a circular economy have spurred interest in activities such as recycling and reclamation of refrigerants. Chemours and Honeywell are uniquely positioned to support these activities and license qualified companies to recycle and reclaim patented fluorochemical refrigerants. The old refrigerant is cleaned, returned to specification and used for service of refrigeration systems that need it. To ensure the integrity of these operations and the safety and quality of the resulting R-448A and R-449A, important criteria have been established for potential program participants including audit requirements and strict record-keeping.

"At Chemours, we strive to create a better world through the power of our chemistry," said Alisha Bellezza President of Thermal & Specialized Solutions at Chemours. "This program demonstrates that commitment by providing the market with peace of mind that reclaimed and recycled HFO refrigerants are safe, legal and meet stringent industry standards. These patented products, R-448A and R-449A, were invented and developed to bring efficient, low-global-warming-potential (GWP) solutions to the market, and this program ensures that qualified recyclers and reclaimers utilize product that originated from an authorized source to be legally available for sale."

"Honeywell is committed to developing ready-now solutions, including our Solstice portfolio of hydrofluoroolefin technology, and supporting our customers in their environmental transformations," said Ken West, president, Honeywell Advanced Materials. "This program is one example and an important step in enabling the broader recovery, recycling and reclamation of fourth generation fluorochemical refrigerants, such as our reduced-GWP, energy-efficient, non-flammable Solstice N40, for a more sustainable future."

About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products include prominent brands such as Ti-Pure(TM), Opteon(TM), Freon(TM), Teflon(TM), Viton(TM), Nafion(TM), and Krytox(TM). The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,200 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

About Honeywell Honeywell (www.honeywell.com) delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

Chemours Forward-Looking Statements This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 and in our Annual Report on Form 10-K for the year ended December 31, 2021. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

Honeywell Forward-Looking Statements This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those that address activities, events or developments that management intends, expects, projects, believes or anticipates will or may occur in the future. They are based on management's assumptions and assessments in light of past experience and trends, current economic and industry conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ significantly from those envisaged by our forward-looking statements. We do not undertake to update or revise any of our forward-looking statements, except as required by applicable securities law. Our forward-looking statements are also subject to risks and uncertainties, including the impact of the COVID-19 pandemic and the Russia-Ukraine conflict, that can affect our performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal commitment, expectation, or prospect set forth in this release can or will be achieved. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005075/en/

SOURCE: The Chemours Company">

INVESTORS
Jonathan Lock 
SVP, Chief Development Officer, Chemours
+1.302.773.2263 
investor@chemours.com

Kurt Bonner, 
Manager, Investor Relations, Chemours 
+1.302.773.0026 
investor@chemours.com 

Sean Meakim 
Investor Relations, Honeywell 
704-627-6200 
sean.meakim@honeywell.com

NEWS MEDIA
Cassie Olszewski
Media Relations and Financial Communications Manager, Chemours
+1.302.219.7140 
media@chemours.com

Stephanie Agresti 
External Communications, Honeywell Advanced Materials 
973-289-0377 
stephanie.agresti@honeywell.com
comtex tracking

COMTEX_419017844/1006/2022-11-16T07:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.